TOKYO, Japan — Kaneka Corporation has begun sales of its i-ED Coil, a medical device used for the embolization of brain aneurysms, in Europe. The product received EC certification under the European Union Medical Device Regulation in July, enabling commercial distribution across European markets through Kaneka Medical Europe N.V.
The i-ED Coil is designed with a specialized wire thickness and structural configuration that provides greater flexibility compared to conventional embolization coils. This allows physicians to pack coils more densely within aneurysms, including those with irregular shapes, which can help reduce the risk of rupture. The device has been steadily adopted in Japan since its launch in 2019.
Kaneka continues to expand its medical portfolio in cardiovascular, peripheral vascular, cerebrovascular, and gastrointestinal treatment technologies. The company aims to increase global access to products such as the i-ED Coil and is targeting 300 billion yen in sales by 2030 across its Health Care Solution business unit.
Guided by the company’s principle of “Wellness First,” Kaneka states that it seeks to contribute to improved access to advanced medical care worldwide while supporting innovation that benefits both global health and everyday life.
